The future of open innovation in cancer looks promising, with increasing recognition of its benefits and growing investments in collaborative platforms. As technologies continue to advance, the potential for more profound insights and faster breakthroughs will likely rise. Moreover, as more stakeholders, including patients, are engaged in the research process, the focus on patient-centered approaches will likely increase, leading to more effective and personalized cancer treatments.
